Medicare AdvantagePrior AuthMedium impact
Tecvayli (teclistamab-cqyv) (Revised)
Humana·FL, KY, SC · Oncology·Medicaid
We identified it
Jul 23, 2026
Summary
This is a revised Prior Authorization policy for Tecvayli (teclistamab-cqyv), a medication covered under Medicare and Medicaid plans in Florida, Kentucky, and South Carolina. The policy update affects authorization requirements for this drug; billing teams must verify current authorization procedures with the source document as only a summary is available.
Action Required
Immediately: Billing team and providers must review the complete Tecvayli prior authorization policy at https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a58681c for Florida, Kentucky, and South Carolina Medicaid and Medicare members. Update internal protocols to reflect any changes in authorization requirements. Verify prior authorization status before processing claims for this drug in affected states. Claims submitted without required prior authorization will be denied. Document the revision date of this policy (1 day old) in your system to ensure staff uses the most current guidance.